Loading...
•
Sep 30, 2025
HCA Q3 2025 Earnings Report
HCA Healthcare posted strong revenue and earnings growth in Q3 2025 and raised its full-year guidance.
Key Takeaways
HCA Healthcare delivered a solid Q3 2025 with increases in revenue, EPS, and net income. The company benefited from operational efficiency and increased admissions, and it raised its full-year guidance as a result.
Revenue rose to $19.161 billion, up from $17.487 billion in Q3 2024
EPS reached $6.96, with both GAAP and adjusted EPS matching
Net income grew to $1.643 billion
Raised full-year revenue, net income, and EPS guidance
Forward Guidance
HCA raised its full-year guidance across revenue, net income, EPS, and adjusted EBITDA, citing strong operational performance and improved volume trends.
Positive Outlook
- Raised revenue guidance to $75.0–$76.5 billion
- Raised net income guidance to $6.495–$6.715 billion
- Increased adjusted EBITDA guidance to $15.25–$15.65 billion
- Raised EPS guidance to $27.00–$28.00
- Stable operating environment with improving volumes
Challenges Ahead
- Ongoing impact from 2024 hurricanes
- Exposure to healthcare policy changes
- High levels of debt and interest expense
- Labor and wage pressures remain a concern
- Potential supply chain and inflationary headwinds
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...